Infection prophylaxis in netrtropenic patients with acute leukaemia—a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin

Journal of Antimicrobial Chemotherapy

Volumn 26, Issue , 1990, Pages 137-142

  Arning, M ^a   Wolf, H H ^a   Aul, C ^a   Heyll, A ^a   Scharf, R E ^a   Schneider, W ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; OFLOXACIN;

ACUTE LEUKEMIA; ADULT; AGED; CONFERENCE PAPER; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION PREVENTION; JAUNDICE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SKIN MANIFESTATION;

BACTERIAL INFECTIONS; CIPROFLOXACIN; COLISTIN; COMPARATIVE STUDY; HUMAN; LEUKEMIA, LYMPHOCYTIC, ACUTE; NEUTROPENIA; OFLOXACIN; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0025633792     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/26.suppl_D.137     Document Type: Article

References (14)

1. Büchner, T., Urbanitz, D., Hiddemann, W., Rühl, H., Ludwig, W. D., Fischer, J. et al. (1985). Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML). Journal of Clinical Oncology 3, 1583–9.
2. Cruciani, M., Concia, E., Navarra, A., Perversi, L., Bonetti, F., Arico, M. et al. (1989). Prophylactic co-trimoxazole versus norfloxacin in neutropenic children—perspective randomized study. Infection 17, 65–9.
3. Dekker, A. W., Rozenberg-Arska, M. & Verhoef, J. (1987). Infection prophylaxis in acute leukaemia: A comparison of dprofloxadn with trimethoprim-sulfamethoxazole and colistin. Annals of Internal Medicine 106, 7–12.
4. Heimpel, H. & Raghavachar, A. (1987). Hematological side effects of co-trimoxazole. Infection 15, Suppl. 5, 248–253.
5. Hiddemann, W., Kreutzmann, H., Straif, K., Ludwig, W. D., Mertelsmann, R., Donhuijsen-Ant, R. et al. (1987). High-dose cytosine arabinoside and mitoxantrone: A highly effective regimen in refractory acute myeloid leukemia. Blood 69, 744–9.
6. Hoelzer, D., Thiel, E., Löffler, H., Bodenstein, H., Plaumann, I., Buchner, T. et al. (1988). Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood 64, 38–47.
7. Hughes, W. T., Duhn, S., Chaudhary, S., Feldman, S., Verzosa, M., Aur, R. J. A. et al. (1977). Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. New England Journal of Medicine 297, 1419–26.
8. Karp, J. E., Merz, W. G., Hendricksen, C., Laughon, B., Redden, T., Bamberger, B. J. et al. (1987). Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. Annals of Internal Medicine 106, 1–7.
9. Kern, W., Kurrle, E. & Vanek, E. (1987a). Ofloxacin for prevention of bacterial infections in granulocytopenic patients. Infection 15, 17–22.
10. Kern, W., Kurrle, E. & Vanek, E. (19876). High risk of streptococcal septicemia after high-dose cytosine arabinoside for acute myeloid leukemia. Klinische Wochenschrift 65, 773–80.
11. Pizzo, P. A., Robichaud, K. J. & Wesley, R., (1982). Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes. Medicine 61, 153–65.
12. Rozenberg-Arska, M., Dekker, W. A. & Verhoef, J. (1985). Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: The effect on fecal flora. Journal of Infectious Diseases 152, 104–7.
13. Wade, J. C. & Schimpff, S. C., (1988). Epidemiology and prevention of infection in the compromised host. In Clinical Approach to Infection in the Compromised Host, 2nd edn (Rubin, R. H. & Young, L. S., Eds), pp. 5–40. Plenum, New York.
14. Wilson, J. M. & Guiney, D. G. (1982). Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukaemia. Isolation of resistant plasmids from strains of enterobacteriaceae causing bacteraemia. New England Journal of Medicine 306, 16–20.